Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the vaxchora market size evolved in recent years?

In recent times, the vaxchora market has observed a XX (HCAGR) expansion. It’s anticipated to escalate from $XX million in 2024 to $XX million in 2025, maintaining a compound annual growth rate (CAGR) at XX%. The historical growth can be connected to an increase in the occurrence of waterborne diseases, consumer’s growing preference for needle-free vaccines, more investments channelled towards global health initiatives, an increasing demand for cholera vaccines, and heightened urbanization alongside poor sanitation conditions.

What are the predictions for the vaxchora market size in the coming years?

Anticipations are high for significant expansion in the Vaxchora market, with a projected XX fold compounded annual growth rate (FCAGR) in the upcoming years. By 2029, the market’s anticipated value is $XX million, thanks to a compound annual growth rate (CAGR) of XX%. This predicted growth for the said period can be credited to a surge in reported cholera outbreaks, an increase in global travel to regions known for cholera, growing consciousness of cholera risks among tourists, a boost in funds for cholera vaccination drives, and the mounting medical tourism industry. The major trends expected in this period include progress in vaccine formulation, oral vaccine advancement, developments in microbiology and immunology research, and the integration of AI in the creation of cholera outbreak prediction models.

Get your vaxchora market report here!

https://www.thebusinessresearchcompany.com/report/vaxchora-global-market-report

What key factors are fueling the growth of the vaxchora market?

The escalation in cholera instances is projected to fuel the Vaxchora market’s expansion in the future. Cholera, an illness induced by vibrio cholerae bacteria, results in serious diarrhea and dehydration due to consumption of tainted water or food. The growing numbers of cholera are attributed to a lack of proper sanitation, limited access to uncontaminated water, climate adaptations, and the rise in people moving to cholera-prone areas. Vaxchora works to prevent cholera by spurring the immune system to generate an antibody response against the Vibrio cholerae serogroup O1, thereby lowering the likelihood of severe diarrhea and dehydration associated with cholera infection. For example, the World Health Organization (WHO), a public health intergovernmental organization based in Switzerland, reported in 2023, a 13% increase in cholera cases and a substantial 71% rise in fatalities compared to 2022, translating to over 4,000 avoidable deaths. The infection expanded to 45 nations, an increase from 44 in 2022 and 35 in 2021. Hence, the burgeoning incidence of cholera is propelling the growth of the Vaxchora market.

How is the global vaxchora market divided into key segments?

The vaxchora market covered in this report is segmented –

1) By Clinical Indication: Prevention Of Cholera; Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Travel Clinics

3) By End User: Adult; Pediatric; Geriatric

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20427&type=smp

Who are the key firms paving the way for growth in the vaxchora market?

Major companies operating in the vaxchora market are Bavarian Nordic A/S

Which trends are expected to transform the vaxchora market?

One predominant trend in the Vaxchora market is the widening of vaccination regional permissions to enhance accessibility and meet the escalating need for cholera avoidance in areas of endemic and high risk. The extension of regional permissions facilitates improved public health results via more comprehensive immunization coverage, and meets the growing global demand for efficient cholera prevention methods. For instance, Bavarian Nordic, a biotech firm based in Denmark, publicized the commercial availability of Vaxchora, the only Canada-approved one-dose oral vaccine for combating cholera, a swift and intense intestinal infection characterized by acute watery diarrhea, in September 2024. The vaccine is dispensed as a single oral dose and safeguards within 10 days.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20427

What regions are contributing significantly to the growth of the vaxchora market?

North America was the largest region in the vaxchora market in 2024. The regions covered in the vaxchora market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Large Volume Parenteral LVP Global Market Report 2025

https://thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Pneumococcal Vaccine Global Market Report 2025

https://thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

Human Papillomavirus (HPV) Vaccine Global Market Report 2025

https://thebusinessresearchcompany.com/report/human-papillomavirus-hpv-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: